Non-ionic surfactants as novel intranasal absorption enhancers: in vitro and in vivo characterization

References

• Ahsan F, Arnold JJ, Meezan E, et al. (2003). Sucrose cocoate, a component of cosmetic preparations, enhances nasal and ocular peptide absorption. Int J Pharm 251:195–203
   PubMed Web of Science ®Google Scholar
• Badary OA, Al-Shabanah OA, Al-Gharably NM, et al. (1998). Effect of cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice. Anticancer Drugs 9:809–15
   PubMed Web of Science ®Google Scholar
• Badgujar SD, Sontakke M, Narute D, et al. (2010). Formulation and evaluation of sumatriptan succinate nasal in-situ gel using fulvic acid as novel permeation enhancer. Int J Pharm Res Dev 2:1–8
   PubMedGoogle Scholar
• Batrakova EV, Han HY, Alakhov V, et al. (1998). Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm Res 15:850–5
   PubMed Web of Science ®Google Scholar
• Chavanpatil MD, Vavia PR. (2005). Nasal drug delivery of sumatriptan succinate. Pharmazie 60:347–9
   PubMed Web of Science ®Google Scholar
• Csaba N, Sánchez A, Alonso MJ. (2006). PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery. J Control Release 113:164–72
   PubMed Web of Science ®Google Scholar
• Ding J, Li J, Mao S. (in press). Development and evaluation of vinpocetine inclusion complex for brain targeting. Asian J Pharm Sci http://dx.doi.org/10.1016/j.ajps.2014.08.008
   Web of Science ®Google Scholar
• Ding J, Na L, Mao S. (2012). Chitosan and its derivatives as the carrier for intranasal drug delivery. Asian J Pharm Sci 7:349–61
   Google Scholar
• Duan X, Mao S. (2010). New strategies to improve the intranasal absorption of insulin. Drug Discov Today 15:416–27
   PubMed Web of Science ®Google Scholar
• Drummond CJ, Fong C, Krodkiewska I, et al. (2003). Sugar fatty acid esters. In: Novel surfactants, surfactant science series, Holmberg K (eds). CRC Press, Taylor & Francis, Inc: London, UK, Vol. 114, 95–128
   Google Scholar
• Femenia-Font A, Balaguer-Fernandez C, Merino V, et al. (2005). Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. Eur J Pharm Biopharm 61:50–5
   PubMed Web of Science ®Google Scholar
• Fischer SM, Parmentier J, Buckley ST, et al. (2012). Oral bioavailability of ketoprofen in suspension and solution formulations in rats: the influence of poloxamer 188. J Pharm Pharmacol 64:1631–7
   PubMed Web of Science ®Google Scholar
• Ganem-Quintanar A, Quintanar-Guerrero D, Falson-Rieg F, et al. (1998). Ex vivo oral mucosal permeation of lidocaine hydrochloride with sucrose fatty acid esters as absorption enhancers. Int J Pharm 173:203–10
   Web of Science ®Google Scholar
• Illum L. (2012). Nasal drug delivery-recent developments and future prospects. J Control Release 161:254–63
   PubMed Web of Science ®Google Scholar
• Jiang XG, Cui JB, Fang XL, et al. (1995). Toxicity of drugs on nasal mucocilia and the method of its evaluation. Acta Pharm Sin 30:848–53
   Google Scholar
• Jose S, Ansa CR, Cinu TA, et al. (2013). Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting. Int J Pharm 441:516–26
   PubMed Web of Science ®Google Scholar
• Kurti L, Veszelka S, Bocsik A, et al. (2012). The effect of sucrose esters on a culture model of the nasal barrier. Toxicol In Vitro 26:445–54
   PubMed Web of Science ®Google Scholar
• Lin H, Gebhardt M, Bian S, et al. (2007). Enhancing effect of surfactants on fexofenadine HCl transport across the human nasal epithelial cell monolayer. Int J Pharm 330:23–31
   PubMed Web of Science ®Google Scholar
• Mao S, Shi Z, Bi D. (1997). Analgin nasal absorption. Chinese Pharm J 32:87–91
   Google Scholar
• Mao S, Yang S, Bi D. (2006). Pharmacodynamics and potential toxicity of intranasally administrated dipyrone. Biol Pharm Bull 29:1355–9
   PubMed Web of Science ®Google Scholar
• Mei D, Mao S, Sun W, et al. (2008). Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats. Eur J Pharm Biopharm 70:874–81
   PubMed Web of Science ®Google Scholar
• Na L, Mao S, Wang J, et al. (2010). Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats. Int J Pharm 397:59–66
   PubMed Web of Science ®Google Scholar
• Onishi H, Imura Y, Uchida M, et al. (2012). Enhancement potential of sucrose laurate (L-1695) on intestinal absorption of water-soluble high molecular weight compounds. Curr Drug Deliv 9:487–94
   PubMed Web of Science ®Google Scholar
• Ozbılgın ND, Saka OM, Bozkır A. (2014). Preparation and in vitro/in vivo evaluation of mucosal adjuvant in situ forming gels with diphtheria toxoid. Drug Deliv 21:140–7
   PubMed Web of Science ®Google Scholar
• Patel SR, Zhong H, Sharma A, et al. (2007). In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate. Eur J Pharm Biopharm 66:296–301
   PubMed Web of Science ®Google Scholar
• Pierce MW. (2010). Transdermal delivery of sumatriptan for the treatment of acute migraine. Neurotherapeutics 7:159–63
   PubMed Web of Science ®Google Scholar
• Pillion DJ, Ahsan F, Arnold JJ, et al. (2002). Synthetic long-chain alkyl maltosides and alkyl sucrose esters as enhancers of nasal insulin absorption. J Pharm Sci 91:1456–62
   PubMed Web of Science ®Google Scholar
• Ravi PR, Aditya N, Patil S, et al. (2013). Nasal in-situ gels for delivery of rasagiline mesylate: improvement in bioavailability and brain localization. Drug Deliv Nov 29. [Epub ahead of print]
   Google Scholar
• Rege BD, Kao JPY, Polli JE. (2002). Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci 16:237–46
   PubMed Web of Science ®Google Scholar
• Salama HA, Mahmoud AA, Kamel AO, et al. (2012). Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route. Colloids Surf B Biointerfaces 100:146–54
   PubMed Web of Science ®Google Scholar
• Seelig A, Gerebtzoff G. (2006). Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding. Expert Opin Drug Metab Toxicol 2:733–52
   PubMed Web of Science ®Google Scholar
• Sheshala R, Khan N, Darwis Y. (2011). Formulation and optimization of orally disintegrating tablets of sumatriptan succinate. Chem Pharm Bull 59:920–8
   PubMed Web of Science ®Google Scholar
• Strickley RG. (2004). Solubilizing excipients in oral and injectable formulations. Pharm Res 21:201–30
   PubMed Web of Science ®Google Scholar
• Szuts A, Szabo-Revesz P. (2012). Sucrose esters as natural surfactants in drug delivery systems – a mini-review. Int J Pharm 433:1–9
   PubMed Web of Science ®Google Scholar
• Udata C, Patel J, Pal D, et al. (2003). Enhanced transport of a novel anti-HIV agent – cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers. Int J Pharm 250:157–68
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Katsumi H, Kusamori K, et al. (2014). Improvement of intestinal absorption of poorly absorbable drugs by various sugar esters. Yakugaku Zasshi 134:47–53
   PubMed Web of Science ®Google Scholar
• Yu C, Gu P, Zhang W, et al. (2011). Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan. Drug Deliv 18:578–85
   PubMed Web of Science ®Google Scholar